The major shareholder Zhang Ming of SOUTH MANGANESE (01091) sold a total of 535 million shares of the company.
(01091) released an announcement regarding Mr. Zhang Ming, the company's major shareholder, submitting a disclosure notice of his equity related to the disposal of his shares on January 28, 2026. On that day, Mr. Zhang sold a total of 535 million shares of the company, equivalent to approximately 10.83% of the total issued shares of the company, at an average selling price of HK$0.24 per share. Following the completion of the disposal, Mr. Zhang no longer holds any shares and is no longer a major shareholder of the company.
SOUTH MANGANESE (01091) announces that Mr. Zhang Ming, a major shareholder of the company, has submitted a disclosure notice regarding the sale of his shares in the company on January 28, 2026. On that day, Mr. Zhang sold a total of 535 million shares of the company, equivalent to approximately 10.83% of the total issued shares of the company, at an average selling price of HK$0.24 per share (the "sale"). Following the completion of the sale, Mr. Zhang no longer holds any shares and is no longer a major shareholder of the company.
Related Articles

Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.

US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.

US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.
Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.

US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.

US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


